Apadamtase Alfa: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Apadamtase Alfa. Educational only — not medical advice.

Labeled uses

ADZYNMA is indicated for prophylactic or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP) [see Use in Specific Populations (8.4) , Clinical Studies (14) ].

Source: FDA labeling via NIH DailyMed (set 22728e96…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.